S&P 500   4,671.63 (+1.74%)
DOW   35,654.39 (+1.21%)
QQQ   393.88 (+1.99%)
AAPL   169.44 (+2.49%)
MSFT   330.55 (+1.34%)
FB   321.87 (+1.26%)
GOOGL   2,915.56 (+1.83%)
AMZN   3,487.65 (+1.76%)
TSLA   1,041.25 (+3.20%)
NVDA   310.12 (+3.25%)
BABA   127.46 (+3.12%)
NIO   34.24 (+5.88%)
CGC   10.38 (+2.27%)
AMD   143.12 (+2.92%)
GE   97.10 (+1.14%)
MU   85.63 (+3.86%)
T   23.22 (-0.26%)
F   19.60 (+1.98%)
DIS   151.76 (+0.92%)
PFE   50.86 (-1.20%)
AMC   30.27 (+5.14%)
ACB   6.15 (+3.02%)
BA   207.93 (+1.00%)
S&P 500   4,671.63 (+1.74%)
DOW   35,654.39 (+1.21%)
QQQ   393.88 (+1.99%)
AAPL   169.44 (+2.49%)
MSFT   330.55 (+1.34%)
FB   321.87 (+1.26%)
GOOGL   2,915.56 (+1.83%)
AMZN   3,487.65 (+1.76%)
TSLA   1,041.25 (+3.20%)
NVDA   310.12 (+3.25%)
BABA   127.46 (+3.12%)
NIO   34.24 (+5.88%)
CGC   10.38 (+2.27%)
AMD   143.12 (+2.92%)
GE   97.10 (+1.14%)
MU   85.63 (+3.86%)
T   23.22 (-0.26%)
F   19.60 (+1.98%)
DIS   151.76 (+0.92%)
PFE   50.86 (-1.20%)
AMC   30.27 (+5.14%)
ACB   6.15 (+3.02%)
BA   207.93 (+1.00%)
S&P 500   4,671.63 (+1.74%)
DOW   35,654.39 (+1.21%)
QQQ   393.88 (+1.99%)
AAPL   169.44 (+2.49%)
MSFT   330.55 (+1.34%)
FB   321.87 (+1.26%)
GOOGL   2,915.56 (+1.83%)
AMZN   3,487.65 (+1.76%)
TSLA   1,041.25 (+3.20%)
NVDA   310.12 (+3.25%)
BABA   127.46 (+3.12%)
NIO   34.24 (+5.88%)
CGC   10.38 (+2.27%)
AMD   143.12 (+2.92%)
GE   97.10 (+1.14%)
MU   85.63 (+3.86%)
T   23.22 (-0.26%)
F   19.60 (+1.98%)
DIS   151.76 (+0.92%)
PFE   50.86 (-1.20%)
AMC   30.27 (+5.14%)
ACB   6.15 (+3.02%)
BA   207.93 (+1.00%)
S&P 500   4,671.63 (+1.74%)
DOW   35,654.39 (+1.21%)
QQQ   393.88 (+1.99%)
AAPL   169.44 (+2.49%)
MSFT   330.55 (+1.34%)
FB   321.87 (+1.26%)
GOOGL   2,915.56 (+1.83%)
AMZN   3,487.65 (+1.76%)
TSLA   1,041.25 (+3.20%)
NVDA   310.12 (+3.25%)
BABA   127.46 (+3.12%)
NIO   34.24 (+5.88%)
CGC   10.38 (+2.27%)
AMD   143.12 (+2.92%)
GE   97.10 (+1.14%)
MU   85.63 (+3.86%)
T   23.22 (-0.26%)
F   19.60 (+1.98%)
DIS   151.76 (+0.92%)
PFE   50.86 (-1.20%)
AMC   30.27 (+5.14%)
ACB   6.15 (+3.02%)
BA   207.93 (+1.00%)
NYSE:ABC

AmerisourceBergen Stock Forecast, Price & News

$119.45
+0.55 (+0.46%)
(As of 12/7/2021 09:39 AM ET)
Add
Compare
Today's Range
$118.70
$119.56
50-Day Range
$114.08
$128.29
52-Week Range
$94.89
$129.54
Volume
1,554 shs
Average Volume
998,078 shs
Market Capitalization
$24.82 billion
P/E Ratio
16.16
Dividend Yield
1.58%
Beta
0.48
30 days | 90 days | 365 days | Advanced Chart
Receive ABC News and Ratings via Email

Sign-up to receive the latest news and ratings for AmerisourceBergen and its competitors with MarketBeat's FREE daily newsletter.


AmerisourceBergen logo

About AmerisourceBergen

AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes an offering of brand-name; specialty brand-name and generic pharmaceuticals; over-the-counter healthcare products; home healthcare supplies and equipment; and related services to healthcare providers, including acute care hospitals and health systems; independent and chain retail pharmacies; mail order pharmacies; medical clinics; and long-term care and alternate site pharmacies. The Other segment focuses on global commercialization services and animal health; and includes AmerisourceBergen Consulting Services ABCS, World Courier, and MWI. The company was founded in 1947 and is headquartered in Conshohocken, PA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
Health Care Distributors
Sector
Medical
CUSIP
03073E10
Employees
42,000
Year Founded
2001

Sales & Book Value

Annual Sales
$213.99 billion
Cash Flow
$12.14 per share
Book Value
$2.81 per share

Profitability

Net Income
$1.54 billion
Pretax Margin
1.04%

Debt

Price-To-Earnings

Miscellaneous

Free Float
148,775,000
Market Cap
$24.82 billion
Optionable
Optionable

Company Calendar

Last Earnings
11/04/2021
Ex-Dividend
11/12/2021
Dividend Payable
11/29/2021
Today
12/07/2021
Next Earnings (Estimated)
2/03/2022
Fiscal Year End
9/30/2022

Social Links


MarketRank

Overall MarketRank

3.51 out of 5 stars

Medical Sector

6th out of 1,394 stocks

Drugs, Proprietaries, & Sundries Industry

1st out of 7 stocks

Analyst Opinion: 2.3Community Rank: 4.4Dividend Strength: 4.2Insider Behavior: 4.2Valuation: 2.5 5 -4 -3 -2 -1 -












AmerisourceBergen (NYSE:ABC) Frequently Asked Questions

Is AmerisourceBergen a buy right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AmerisourceBergen in the last twelve months. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AmerisourceBergen stock.
View analyst ratings for AmerisourceBergen
or view top-rated stocks.

How has AmerisourceBergen's stock price been impacted by COVID-19 (Coronavirus)?

AmerisourceBergen's stock was trading at $84.96 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ABC stock has increased by 40.6% and is now trading at $119.45.
View which stocks have been most impacted by COVID-19
.

When is AmerisourceBergen's next earnings date?

AmerisourceBergen is scheduled to release its next quarterly earnings announcement on Thursday, February 3rd 2022.
View our earnings forecast for AmerisourceBergen
.

How were AmerisourceBergen's earnings last quarter?

AmerisourceBergen Co. (NYSE:ABC) released its earnings results on Thursday, November, 4th. The company reported $2.39 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $2.36 by $0.03. The business had revenue of $58.90 billion for the quarter, compared to analyst estimates of $57.05 billion. AmerisourceBergen had a net margin of 0.72% and a trailing twelve-month return on equity of 2,040.08%. The company's quarterly revenue was up 19.6% compared to the same quarter last year. During the same period in the previous year, the company earned $1.89 earnings per share.
View AmerisourceBergen's earnings history
.

How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?

AmerisourceBergen announced a quarterly dividend on Friday, November 5th. Stockholders of record on Monday, November 15th will be given a dividend of $0.46 per share on Monday, November 29th. This represents a $1.84 annualized dividend and a dividend yield of 1.54%. The ex-dividend date is Friday, November 12th. This is a positive change from AmerisourceBergen's previous quarterly dividend of $0.44.
View AmerisourceBergen's dividend history
.

Is AmerisourceBergen a good dividend stock?

AmerisourceBergen pays an annual dividend of $1.84 per share and currently has a dividend yield of 1.58%. AmerisourceBergen has been increasing its dividend for 17 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of AmerisourceBergen is 24.90%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, AmerisourceBergen will have a dividend payout ratio of 15.86% next year. This indicates that AmerisourceBergen will be able to sustain or increase its dividend.
View AmerisourceBergen's dividend history.

What guidance has AmerisourceBergen issued on next quarter's earnings?

AmerisourceBergen updated its FY 2022 earnings guidance on Thursday, November, 18th. The company provided earnings per share guidance of $10.500-$10.800 for the period, compared to the Thomson Reuters consensus EPS estimate of $10.570. The company issued revenue guidance of -.

What price target have analysts set for ABC?

10 analysts have issued twelve-month price objectives for AmerisourceBergen's shares. Their forecasts range from $114.00 to $162.00. On average, they anticipate AmerisourceBergen's share price to reach $142.50 in the next year. This suggests a possible upside of 19.3% from the stock's current price.
View analysts' price targets for AmerisourceBergen
or view top-rated stocks among Wall Street analysts.

Who are AmerisourceBergen's key executives?

AmerisourceBergen's management team includes the following people:
  • Steven H. Collis, Chairman, President & Chief Executive Officer (LinkedIn Profile)
  • James Francis Cleary, Chief Financial Officer & Executive Vice President
  • Kathy Habecker Gaddes, Chief Compliance Officer & Executive Officer
  • Gina K. Clark, Chief Communications & Administration Officer, EVP (LinkedIn Profile)
  • Sun Park, Executive Vice President

What is Steve Collis' approval rating as AmerisourceBergen's CEO?

447 employees have rated AmerisourceBergen CEO Steve Collis on Glassdoor.com. Steve Collis has an approval rating of 83% among AmerisourceBergen's employees.

Who are some of AmerisourceBergen's key competitors?

What other stocks do shareholders of AmerisourceBergen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AmerisourceBergen investors own include NVIDIA (NVDA), Intel (INTC), AbbVie (ABBV), Walt Disney (DIS), CVS Health (CVS), Johnson & Johnson (JNJ), AT&T (T), JPMorgan Chase & Co. (JPM), Home Depot (HD) and Pfizer (PFE).

What is AmerisourceBergen's stock symbol?

AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."

Who are AmerisourceBergen's major shareholders?

AmerisourceBergen's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (5.30%), Boston Partners (2.30%), Capital Research Global Investors (1.64%), FIL Ltd (1.43%), Geode Capital Management LLC (1.26%) and Glenview Capital Management LLC (0.91%). Company insiders that own AmerisourceBergen stock include Dermot Mark Durcan, Gina Clark, Henry Wadsworth Mcgee III, Jane E Md Henney, John G Chou, John G Chou, Kathleen W Hyle, Kathy H Gaddes, Lazarus Krikorian, Robert P Mauch, Silvana Battaglia and Steven H Collis.
View institutional ownership trends for AmerisourceBergen
.

Which major investors are selling AmerisourceBergen stock?

ABC stock was sold by a variety of institutional investors in the last quarter, including American International Group Inc., Neuberger Berman Group LLC, BlackRock Inc., Assenagon Asset Management S.A., Schonfeld Strategic Advisors LLC, Renaissance Technologies LLC, Pensioenfonds Rail & OV, and Deutsche Bank AG. Company insiders that have sold AmerisourceBergen company stock in the last year include Gina Clark, Henry Wadsworth Mcgee III, John G Chou, Robert P Mauch, Silvana Battaglia, and Steven H Collis.
View insider buying and selling activity for AmerisourceBergen
or view top insider-selling stocks.

Which major investors are buying AmerisourceBergen stock?

ABC stock was acquired by a variety of institutional investors in the last quarter, including Fort Washington Investment Advisors Inc. OH, Man Group plc, Goldman Sachs Group Inc., Point72 Asset Management L.P., Massachusetts Financial Services Co. MA, Glenview Capital Management LLC, Polar Capital Holdings Plc, and BNP Paribas Arbitrage SA.
View insider buying and selling activity for AmerisourceBergen
or or view top insider-buying stocks.

How do I buy shares of AmerisourceBergen?

Shares of ABC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AmerisourceBergen's stock price today?

One share of ABC stock can currently be purchased for approximately $119.45.

How much money does AmerisourceBergen make?

AmerisourceBergen has a market capitalization of $24.82 billion and generates $213.99 billion in revenue each year. The company earns $1.54 billion in net income (profit) each year or $7.39 on an earnings per share basis.

How many employees does AmerisourceBergen have?

AmerisourceBergen employs 42,000 workers across the globe.

Does AmerisourceBergen have any subsidiaries?

The following companies are subsidiares of AmerisourceBergen: ASD Specialty Healthcare LLC, Access M.D., Alliance Healthcare, Amerisource Receivables Financial Corporation, AmerisourceBergen Drug Corporation, AmerisourceBergen Global Holdings GmbH, AmerisourceBergen Global Manufacturer Services GmbH, AmerisourceBergen Group AG, AmerisourceBergen International Holdings Inc., AmerisourceBergen Luxembourg S.a.r.L., AmerisourceBergen Services Corporation, AmerisourceBergen Specialty Group LLC, Anderson Packaging, AutoMed Technologies, BPL Group LLC, BPLH Ireland Unlimited Company, Bellco Health, Brecon Pharmaceuticals, Bridge Medical Inc, CD Smith Healthcare, H. D. Smith, IgG America, International Oncology Network Solutions Inc., IntrinsiQ, Lash Group, MWI Veterinary Supply, MWI Veterinary Supply Co., MWI Veterinary Supply Inc., Network for Medical Communications & Research, PharMEDium Healthcare, Pharmacy Healthcare Solutions, Premier Source, St. Francis Group, Trent Drug, US Bioservices, World Courier, World Courier Group S.à r.l., and Xcenda.

When was AmerisourceBergen founded?

AmerisourceBergen was founded in 2001.

What is AmerisourceBergen's official website?

The official website for AmerisourceBergen is www.amerisourcebergen.com.

Where are AmerisourceBergen's headquarters?

AmerisourceBergen is headquartered at 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087.

How can I contact AmerisourceBergen?

AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company can be reached via phone at (610) 727-7000, via email at [email protected], or via fax at 800-640-5221.


This page was last updated on 12/7/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.